Cargando…
Association of Insurance Status and Extent of Organ Involvement With Survival Among Patients With Stage IV Cancer
This cohort study examines the association of insurance status and extent of metastatic organ involvement with survival among patients with stage IV cancer to better understand outcome disparities in the US.
Autores principales: | Zhan, Peter L., Canavan, Maureen E., Ermer, Theresa, Pichert, Matthew D., Li, Andrew X., Maduka, Richard C., Boffa, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206181/ https://www.ncbi.nlm.nih.gov/pubmed/35713907 http://dx.doi.org/10.1001/jamanetworkopen.2022.17581 |
Ejemplares similares
-
Nonregional Lymph Nodes as the Only Metastatic Site in Stage IV Esophageal Cancer
por: Zhan, Peter L., et al.
Publicado: (2022) -
Utilization and Outcomes of Radiation in Stage IV Esophageal Cancer
por: Zhan, Peter Lee, et al.
Publicado: (2022) -
Immunotherapy After Chemotherapy and Radiation for Clinical Stage III Lung Cancer
por: Pichert, Matthew D., et al.
Publicado: (2022) -
Revisiting Indications for Brain Imaging During the Clinical Staging Evaluation of Lung Cancer
por: Pichert, Matthew D., et al.
Publicado: (2022) -
Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US
por: Ermer, Theresa, et al.
Publicado: (2022)